Lineage Cell Therapeutics, Stock Return On Asset
| LCTX Stock | ILA 195.80 32.10 14.09% |
Lineage Cell Therapeutics, fundamentals help investors to digest information that contributes to Lineage Cell's financial success or failures. It also enables traders to predict the movement of Lineage Stock. The fundamental analysis module provides a way to measure Lineage Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lineage Cell stock.
Lineage |
Lineage Cell Therapeutics, Company Return On Asset Analysis
Lineage Cell's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Lineage Cell Return On Asset | -13.19 |
Most of Lineage Cell's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lineage Cell Therapeutics, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Lineage Cell Therapeutics, has a Return On Asset of -13.19. This is much lower than that of the sector and significantly lower than that of the Return On Asset industry. The return on asset for all Israel stocks is notably higher than that of the company.
Lineage Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lineage Cell's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lineage Cell could also be used in its relative valuation, which is a method of valuing Lineage Cell by comparing valuation metrics of similar companies.Lineage Cell is currently under evaluation in return on asset category among its peers.
Lineage Fundamentals
| Return On Equity | -10.82 | |||
| Return On Asset | -13.19 | |||
| Current Valuation | 1.3 B | |||
| Shares Owned By Insiders | 4.50 % | |||
| Shares Owned By Institutions | 43.81 % | |||
| Revenue | 1.83 M | |||
| Gross Profit | 1.44 M | |||
| EBITDA | (24.77 M) | |||
| Net Income | (11.93 M) | |||
| Cash And Equivalents | 68.75 M | |||
| Cash Per Share | 0.41 X | |||
| Total Debt | 2.9 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 10.58 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (23.33 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 49 | |||
| Beta | 1.84 |
About Lineage Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lineage Cell Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lineage Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lineage Cell Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lineage Stock
Lineage Cell financial ratios help investors to determine whether Lineage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lineage with respect to the benefits of owning Lineage Cell security.